Following yesterday’s review of a dozen key oral abstract sessions to watch out for at ASCO18 next month including lung cancer and others, we now take a look at the other side of the coin with a dozen key poster abstracts to explore.

  • Which topics jump out this year?
  • What new targets and molecules are the emergent gems to think about?
  • What can we learn from translational and early combination clinical data?

Take a walk with us on our journey to Chicago ahead of the data drop at 5pm…

To learn more and get a heads up on our latest oncology insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by